Eisai has entered an exclusive global licensing agreement with CORE Biomedicine for several preclinical oncology programmes.The post Eisai and CORE...
argenx has entered into a definitive agreement to acquire Forte Biosciences for approximately $2.2bn in total equity value.The post argenx...
Labcorp has launched Marker by Labcorp Genetic Health Panel, a test aimed at expanding consumer access to information about hereditary...
AstraZeneca has released findings from two Phase III studies, reporting outcomes for Ultomiris in thrombotic microangiopathy following HSCT-TMA and Sone-Ve...
EndoQuest Robotics has concluded subject enrolment in the PARADIGM trial, assessing the Endoluminal Surgical (ELS) System.The post Enrolment concludes in...
Estrella Immunopharma has dosed the first patient in the dose-expansion segment of its STARLIGHT-1 Phase I/II trial, assessing EB103 for...
The FDA has approved Kenvue’s Tylenol with Naproxen, the first OTC fixed-dose combination of acetaminophen and naproxen sodium.The post Kenvue’s Tylenol...
Venus Medtech has concluded patient enrolment in the confirmatory clinical trial for the Venus-PowerX transcatheter aortic valve system in China.The...
Bio-Thera Solutions has started dosing in a Phase I clinical trial of BAT8013, an ADC designed to target CD25, in...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.